-
Je něco špatně v tomto záznamu ?
Hypertriglyceridemic Waist in Patients with Type 2 Diabetes: Its Relationship to Selected Markers of Vascular Damage
D. Karasek, J. Spurna, D. Macakova, L. Cibickova, O. Krystynik, V. Kucerova, J. Ulehlova, L. Slavik
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
34096797
DOI
10.1089/met.2021.0019
Knihovny.cz E-zdroje
- MeSH
- biologické markery krev MeSH
- diabetes mellitus 2. typu * epidemiologie MeSH
- hypertriglyceridemický pas * epidemiologie MeSH
- inhibitor aktivátoru plazminogenu 1 krev MeSH
- kardiovaskulární nemoci * krev diagnóza epidemiologie MeSH
- lidé MeSH
- studie případů a kontrol MeSH
- von Willebrandův faktor analýza MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Background: To evaluate the association between hypertriglyceridemic waist (HTGW), a promising marker of visceral adiposity and cardiovascular (CV) risk, and different indicators of vascular damage in type 2 diabetes (T2D) patients. Methods: This case-control study included 161 patients with T2D (91 males, 70 females) and 40 healthy controls (24 males, 16 females). HTWG was defined as waist circumference >90 cm in men or >85 cm in women and triglyceride concentrations >2 mmol/L. In addition to anthropometric and metabolic parameters, markers of endothelial dysfunction, namely von Willebrand factor (vWF) and plasminogen activator inhibitor-1 (PAI-1), were assessed. Arterial stiffness parameters were examined using the SphygmoCor system. Results: Individuals with T2D and HTGW showed the highest elevation of PAI-1 levels and significantly increased vWF levels compared with healthy controls. No significant differences in arterial stiffness markers were observed between T2D individuals. Age and, for several markers, systolic and/or diastolic blood pressure were identified as the main predictors for arterial stiffness, whereas PAI-1 and vWF levels were predicted by metabolic parameters. Conclusions: HTGW represents increased CV risk in T2D patients, mainly due to endothelial damage. The presence of HTGW had no significant effect on arterial stiffness compared with other T2D individuals.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012260
- 003
- CZ-PrNML
- 005
- 20220506130358.0
- 007
- ta
- 008
- 220425s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/met.2021.0019 $2 doi
- 035 __
- $a (PubMed)34096797
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Karasek, David $u 3rd Department of Internal Medicine-Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic, Olomouc, Czech Republic $1 https://orcid.org/0000000293094952 $7 stk2007415300
- 245 10
- $a Hypertriglyceridemic Waist in Patients with Type 2 Diabetes: Its Relationship to Selected Markers of Vascular Damage / $c D. Karasek, J. Spurna, D. Macakova, L. Cibickova, O. Krystynik, V. Kucerova, J. Ulehlova, L. Slavik
- 520 9_
- $a Background: To evaluate the association between hypertriglyceridemic waist (HTGW), a promising marker of visceral adiposity and cardiovascular (CV) risk, and different indicators of vascular damage in type 2 diabetes (T2D) patients. Methods: This case-control study included 161 patients with T2D (91 males, 70 females) and 40 healthy controls (24 males, 16 females). HTWG was defined as waist circumference >90 cm in men or >85 cm in women and triglyceride concentrations >2 mmol/L. In addition to anthropometric and metabolic parameters, markers of endothelial dysfunction, namely von Willebrand factor (vWF) and plasminogen activator inhibitor-1 (PAI-1), were assessed. Arterial stiffness parameters were examined using the SphygmoCor system. Results: Individuals with T2D and HTGW showed the highest elevation of PAI-1 levels and significantly increased vWF levels compared with healthy controls. No significant differences in arterial stiffness markers were observed between T2D individuals. Age and, for several markers, systolic and/or diastolic blood pressure were identified as the main predictors for arterial stiffness, whereas PAI-1 and vWF levels were predicted by metabolic parameters. Conclusions: HTGW represents increased CV risk in T2D patients, mainly due to endothelial damage. The presence of HTGW had no significant effect on arterial stiffness compared with other T2D individuals.
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 12
- $a kardiovaskulární nemoci $x krev $x diagnóza $x epidemiologie $7 D002318
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 12
- $a diabetes mellitus 2. typu $x epidemiologie $7 D003924
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hypertriglyceridemický pas $x epidemiologie $7 D064250
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a inhibitor aktivátoru plazminogenu 1 $x krev $7 D017395
- 650 _2
- $a von Willebrandův faktor $x analýza $7 D014841
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Spurna, Jaromira $u 3rd Department of Internal Medicine-Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic, Olomouc, Czech Republic
- 700 1_
- $a Macakova, Dominika $u 3rd Department of Internal Medicine-Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic, Olomouc, Czech Republic
- 700 1_
- $a Cibickova, Lubica $u 3rd Department of Internal Medicine-Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic, Olomouc, Czech Republic
- 700 1_
- $a Krystynik, Ondrej $u 3rd Department of Internal Medicine-Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic, Olomouc, Czech Republic
- 700 1_
- $a Kucerova, Veronika $u Department of Clinical Biochemistry, University Hospital Olomouc, Czech Republic, Olomouc, Czech Republic
- 700 1_
- $a Ulehlova, Jana $u Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic, Olomouc, Czech Republic $1 https://orcid.org/0000000337672129
- 700 1_
- $a Slavik, Ludek $u Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic, Olomouc, Czech Republic
- 773 0_
- $w MED00007472 $t Metabolic syndrome and related disorders $x 1557-8518 $g Roč. 19, č. 7 (2021), s. 393-400
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34096797 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130350 $b ABA008
- 999 __
- $a ok $b bmc $g 1789727 $s 1163461
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 19 $c 7 $d 393-400 $e 20210604 $i 1557-8518 $m Metabolic syndrome and related disorders $n Metab Syndr Relat Disord $x MED00007472
- LZP __
- $a Pubmed-20220425